Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

Junyu Huo; Liqun Wu; Yunjin Zang

doi:10.12659/MSM.925494

18 September 2020 : Database Analysis

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

Junyu Huo^1ABCDEF, Liqun Wu^1AEF*, Yunjin Zang^1AE

DOI: 10.12659/MSM.925494

Med Sci Monit 2020; 26:e925494

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Correlation of risk score with clinicopathological characteristics. (A) Histopathological grade. (B) Vascular tumor cell type. (C) AJCC stage. (D) New tumor event after treatment initiation. (E) Cancer status.

Back to the Article

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

Your Privacy